Locations:
Search
$15.4M grant to fund work on atypical Alzheimer’s, Lewy body dementia and more
Links are centered on neuroinflammation and microvascular injury, network medicine study finds
Longitudinal study implicates a specific pathway in mild cognitive impairment stage
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic-developed “compound 3” begins testing in preclinical Alzheimer’s model
Third annual report shows shift toward prevention studies, disease-modifying therapies
Most substantial reversal of amyloid deposition in an animal study to date
Advertisement
Advertisement